Main > A1. CORP. INDEX. G-Gm > GlaxoSmithKline/P C2
This data is not available for free
GlaxoSmithKline/P C2's subsections
2000. 01.24.2000. (Headquarters)
2000. 03.13.2000. (Proteomics)
2000. 05.15.2000. (EU Clearing)
2000. 06.26.2000. (St Johns Wort)
2000. 07.26.2000. (Obesity..)
2000. 08.07.2000. (Sales)
2000. 08.23.2000. (Ondansetron)
2000. 09.18.2000. (Merger Date)
2001. 02.19.2001. (Animal Test.)
2001. 03.07.2001. (AIDS)
2001. 04.23.2001. (AIDS)
2001. 05.21.2001. (Outsourcing)
2001. 06.07.2001. (Obesity)
2001. 07.09.2001. (Gene)
2001. 08.27.2001. (Combinatorial)
2001. 09.01.2001. (AIDS)
2001. 10.01.2001. (Diabetes)
2001. 10.01.2001. (Onco.)
2001. 10.08.2001. (AIDS)
2002. 01.18.2002. (AntiSmoke)
2002. 02.01.2002. (AIDS)
2002. 02.05.2002. (MicroChemistry)
2002. 03.18.2002. (Business Sale)
2002. 04.01.2002. (Patent)
2002. 04.08.2002. (Onco.)
2002. 04.22.2002. (Antibiotics)
2002. 04.22.2002. (Osteoporosis)
2002. 05.06.2002. (AIDS)
2002. 05.06.2002. (Depression)
2002. 05.13.2002. (Biological)
2002. 05.22.2002. (Diabetes)
2002. 06.10.2002. (BioAvailability)
2002. 06.10.2002. (Depression)
2002. 06.10.2002. (Onco.)
2002. 07.08.2002. (Onco.)
2002. 07.22.2002. (Ranking)
2002. 08.12.2002. (Uni. Cambridge)
2002. 08.26.2002. (Tech. Program)
2002. 09.03.2002. (Antibiotics)
2002. 09.23.2002. (Antibiotics)
2002. 09.23.2002. (Depression/1)
2002. 09.23.2002. (Depression/2)
2002. 10.14.2002. (Alliance)
2002. 10.14.2002. (Subscriber of)
2002. 10.21.2002. (Chem. Serv Deal)
2002. 10.28.2002. (ImPotency)
2002. 11.04.2002. (Alliance with)
2002. 11.04.2002. (Onco.)
2002. 11.11.2002. (Cardiology)
2002. 12.02.2002. (AIDS)
2002. 12.02.2002. (Depression)
2002. 12.02.2002. (Diabetes)
2002. 12.02.2002. (Genomics)
2002. 12.02.2002. (Historics)
2002. 12.02.2002. (ImPotency)
2002. 12.02.2002. (Market Share)
2002. 12.02.2002. (Pneumology)
2002. 12.16.2002. (Partnerships)
2002. 12.23.2002. (Depression)
2002. Winter. (Chemical Genetics)
2003. 01.13.2003. (Pneumology)
2003. 01.27.2003. (Executive)
2003. 01.27.2003. (Onco.)
2003. 02.24.2003. (Polymorphism)
2003. 03.03.2003. (Onco.)
2003. 03.17.2003. (Antibiotics)
2003. 03.17.2003. (Depression)
2003. 03.17.2003. (Process Chem.)
2003. 03.17.2003. (Ranking)
2003. 04.07.2003. (Alliance)
2003. 04.21.2003. (Business Dev.)
2003. 04.21.2003. (Executive)
2003. 04.21.2003. (R&D/CEDD)
2003. 05.05.2003. (AIDS)
2003. 05.12.2003. (ChemProteomics)
2003. 05.26.2003. (AIDS)
2003. 05.26.2003. (Executive)
2003. 07.23.2003. (AntiFungals)
2003. 08.04.2003. (Packaging)
2003. 08.08.2003. (Urology)
2003. 09.15.2003. (NonSpecific Inh)
2003. 09.22.2003. (Protein Crystal)
2003. 10.22.2003. (Ranbaxy Deal)
2003. 11.27.2003. (Urology)
2004. 02.16.2004. (Discov Tool/HTS)
2004. 02.16.2004. (Executives)
2004. 02.16.2004. (R&D)
2005. 01.24.2005. (Ambit Bio Deal)
2005. 05.30.2005. (External R&D)
2005. 06.27.2005. (Vitae Pharma.)
2005. 10.25.2005. (AIDS>Fusion)
2006. 02.27.2006. (Singapore)
2006. 04.03.2006. (Pharmacopeia)
2006. 04.03.2006. (Sirna)
2006. 07.26.2006. Avian Flu Vacc.
2006. 08.07.2006. (Onco.)
2006. 08.24.2006. (Gastro.>IBD)
2006. 08.28.2006. (Compd Manager)
2006. 12.19.2006. (Genmab AS)
2007. 01.22.2007. Engg Head
2007. 01.22.2007. Engg Tech Directo
2007. 02.19.2007. NonExec Director
2007. 06.04.2007. CN>R&D Center
2007. 07.27.2007. (Targacept)
2007. 09.24.2007. (US Antibiotics)
2007. 10.08.2007. (Anacor Pharma.)
2007. 10.10.2007. (Onco.)
2007. 10.15.2007. (Onco.)
2007. 10.18.2007. (Diab.>TZD)
2007. 10.19.2007. (Allergy)
2007. 10.23.2007. (Tolerx Inc)
2007. 11.20.2007. (Rheumatoid A,)
2007. 11.21.2007. (Corp. Acq.)
2007. 12.03.2007. (GastroEntero.)
2007. 12.10.2007. (AntiBacterials.)
2007. 12.10.2007. (Neurology)
2007. 12.10.2007. (Onco.)
2007. 12.13.2007. (Neurology) >
2007. 12.18.2007. (OsteoArthritis)
2007. 12.20.2007. (Onco.>ITP)
2008. 01.03.2008. (Asthma) >
2008. 01.15.2008. (Neurology)
2008. 02.04.2008. (Onco.)
2008. 02.28.2008. (Neurology)
2008. 03.14.2008. (HES)
2008. 03.18.2008. (Onco.)
2008. 04.02.2008. (AIDS)
2008. 04.03.2008. (RotaVirus Vacc.)
2008. 04.17.2008. MicroRNA Target
2008. 04.25.2008. Cardio.>PAH
2008. 06.27.2008. Onco.>Exelixis
2008. 07.14.2008. Neuro.>Insomnia
2008. 07.28.2008. Aspen Pharmacare
2008. 07.28.2008. Harvard Uni.
2008. 07.28.2008. Shift In Bus.
2008. 07.28.2008. Uni. Cambridge
2008. 08.28.2008. Neuro.>Epilepsy
2008. 10.20.2008. Egypt BMS
2009. 01.23.2009. UCB
2009. 02.06.2009. Idenix>AIDS
2009. 02.23.2008. CEO
2009. 04.16.2009. New AIDS Co.
2009. 04.20.2009. Gov. Affairs
2009. 06.02.2009. Concert Pharma.
2009. 06.09.2009. Shenzhen Neptunus
2009. 06.23.2009. Chroma Therapeuti
2009. 07.20.2009. ImmunoTherapy
2009. 10.06.2009. CN>Vaccines
2009. 11.02.2009. Epilepsy
2010. 01.11.2010. Gastro.>Crohns
2010. 03.29.2010. Onco.>Prostate C.
2010. 03.31.2010. Isis Pharma.
2010. 06.10.2010. LA>AR>Corp Acq
2010. 06.14.2010. Urology>BPH
2010. 08.05.2010. Antibiotics
2010. 10.12.2010. Uni. Nottingham
2010. 10.18.2010. Fondazio Telethon
2010. 10.26.2010. Settlement>DOJ
2010. 11.26.2010. JSC Binnopharm
2010. 12.07.2010. CN>Corp. Acq.
2010. 12.21.2010. Pneumo.>COPD
2011. 01.17.2011. Q4 2010 Legal
2011. 02.07.2011. Rheuma.>SLE
2011. 04.06.2011. Neuro.>RLS
2011. 04.11.2011. Onco.>PI3K Inh.
2011. 05.31.2011. MaRS Innovation
2011. 06.13.2011. Neuro.>Epilepsy
2011. 07.14.2011. Rheuma.>SLE
2012. 03.15.2012. OTC Brands In EU
2012. 03.22.2012. Investments in UK
2012. 04.26.2012. Onco.>Sarcoma
2012. 04.26.2012. Uni. Nottingham
2012. 05.01.2012. Yale Uni.
2012. 05.16.2012. Theravance
2012. 05.29.2012. CDRD
2012. 06.07.2012. Neuro.>PHN
2012. 06.14.2012. Meningitis Vacc.
2012. 07.12.2012. Onco.>Breast C.
2012. 08.03. Human Genome Sciences
2012. 08.23. Rheuma.>RA
2012. 09.17. Pneumococcal Vacc
2012. 09.26. Pneumo.>COPD &
2012. 10.01. Onco.>Kidney C.
2012. 10.11. OpenNess Efforts
2012. 10.29. AIDS
2012. 11.08. XenoPort
2012. 12.14. Anthrax
2012. 12.17. Quadri Influenza Vacc.
2013. 01.28. Biological E Ltd.
2013. 02.05. IN Consumer H.
2013. 02.07. Onco.>Melanoma EU
2013. 02.11. Obesity/VU
2013. 03.26. Influenza Vacc.
2013. 04.09. SG>A*STAR
2013. 04.10. ElectroCeuticals
2013. 05.03. Open Innovation
2013. 05.13. Pneumo.>COPD F+V
2013. 05.22. Antibiotics
2013. 05.29. Corp. Acq.
2013. 06.18. Thrombosis Brands &
2013. 07.24. Onco.>Melanoma Mono.
2013. 08.08. Launch APVC Ltd.
2013. 09.09. Nutritional Drinks
2013. 09.24. Thrombocytopenia
2013. 09.30. Divest Thrombosis
2013. 10.08. Malaria>Vaccine
2013. 10.25. BR>FAPESP
2013. 10.29. Vaccines>VxDP
2013. 11.06. Competition
2013. 11.25. Diab.>Rosiglitazone
2013. 11.25. H5N1 Influenza Vacc.
2013. 12.06. Pneumo.>Asthma>F+V
2013. 12.11. UK Mfg. & Science
2013. 12.18. BioElectronics Res.
2013. 12.20. Malaria>Tafenoquine
2014. 01.09. Onco.>Melanoma Combi
2014. 01.13. DMD>Prosensa
2014. 01.13. Onco.>NSCLC>with BRAF
2014. 02.03. Hemato.>SAA
2014. 02.17. Technion
2014. 03.10. IN>GSK Pte Ltd.
2014. 03.14. Pneumo.>COPD U+V
2014. 03.27. EMBL-EBI & WTSI
2014. 03.31. Onco.>Ovarian C.
2014. 04.15. Diab.>Albiglutide
2014. 04.17. Onco.>CLL
2014. 04.22. Novartis 3-Part Deal
2014. 04.30. Pneumo.>COPD U
2014. 05.13. CV.>Darapladib
2014. 05.19. Onco.>B Cell Lymphoma
2014. 06.05. CV>ACS>Losmapimod
2014. 07.16. Pneumo>COPD>FF/UMEC/VI
2014. 07.24. Allergy
2014. 08.20. Pneumo.>Asthma>F
2014. 11.05. Pneumo.>Asthma>M
2015. 02.11. Acq. GlycoVaxyn AG
2015. 03.03. AU>Opiate Bus.>Sun
2015. 03.17. Dementia Research
2015. 03.23. CSHL
2015. 04.02. USA>Vaccine Center
2015. 05.10. Uni. NC
2015. 07.14. Francis Crick Institut
2015. 11.04. Pneumo.>Asthma>M >12Y
2016. 04.20. Sanford Burnham
2016. 08.01. Galvani BioElectronics
2016. 12.02. Pneumo.>COPD F+V
2017. 05.01. Rheuma.>SLE
2017. 09.18. Pneumo>COPD>FF/UMEC/VI
2017. 11.16. Pneumo>COPD>FF/UMEC/VI
2018. 04.12. Orchard Therapeutics
2018. 07.25. 23andMe
2018. 12.03. Acq. Tesaro
2018. 12.19. Consumer Healthcare
2019. 02.05. Onco.>Merck KGaA
2019. 06.13. Uni. California
2019. 09.11. Acq. Sitari Pharma.
2019. 09.12. Pneumo.>Asthma>M 6-11Y
2020. 04.06. COVID-19 Vir Bio ..
2020. 08.06. Onco.>R/R MM USA>OK
2020. 08.26. Onco.>R/R MM EU>OK
2020. 09.09. Pneumo>Asth>FF/UMEC/VI
2020. 12.17. Nephro.>LN>USA>OK
2021. 03.16. COVID-19 vaccine
2021. 04.22. Onco.>Endometrial C.
2021. 06.14. Onco.>iTeos Therapeuti
2021. 07.02. Alector
2021. 07.26. Shingles>Prevn>USA>OK
2021. 08.17. Onco.>Solid Tumors ..
2021. 12.02. COVID-19>Treat.>UK>OK
2022. 04.13. Acq. Sierra Oncology
2022. 05.31. Acq. Affinivax Inc.
2022. 06.06. measles vacc.>USA>OK
2022. 07.27. Nephro.>LN>USA>OK
2022. 10.10. Cough Vaccine>USA>OK
2023. 02.01. USA FDA Approval
2023. 02.10. USA FDA Approval
2023. 04.18. Acq. BELLUS Health
2023. 05.03. US FDA approves
2023. 09.15. Onco.>Myelofibrosis
Beecham/P
Burroughs Wellcome Co./P
CNS Inc./P
Glaxco/P
Glaxo/P
GlaxoSmithKline Biologicals/P
GlaxoSmithKline Consumer/P
GlaxoWellcome Inc./P
Patents
Products C2
SmithKline & French Laboratories/P
SmithKline Beecham Biologicals/P
SmithKline Beecham/P
Web-Site (Australia)
Web-Site (UK)
Z - OK
GlaxoSmithKline/P C2's products
This section has no products